Ángel V. Espinosa
Ángel V. Espinosa has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Javier Ripollés-Melchor
Department of Anaesthesiology, Hospital Universitario Infanta Leonor, Madrid, Spain
2 shared publications - María José Colomina
Department of Anesthesiology, Bellvitge University Hospital, 08907 L’Hospitalet de Llobregat, Spain
2 shared publications - Rachel Budithi
Froedtert Hospital Medical College of Wisconsin, Milwakee, USA
2 shared publications A. Abad Gurumeta
Anesthesia department, Hospital Universitario Infanta Leonor, Madrid, Spain; Universidad Complutense de Madrid, Madrid, Spain
1 shared publicationA. Malvido
Department of Gastroenterology University Hospital Carlos B. Udaondo, Buenos Aires, Argentina
1 shared publication- Alfredo Abad-Gurumeta
Department of Anesthesiology, Infanta Leonor Hospital, 28031 Madrid, Spain
1 shared publication
Latest Publications
- 28 September 2026
- Published by Wolters Kluwer Health in Anesthesiology
Intraoperative blood pressure targeting in noncardiac surgery: a Bayesian random-effects meta-analysis of randomized trials
Background: Whether protocolized intraoperative arterial pressure-targeting strategies provide incremental benefit beyond contemporary usual care remains uncertain. We performed a Bayesian meta-analysis of randomized trials in major noncardiac surgery. Methods: MEDLINE, Embase, and Cochrane CENTRAL were searched from inception to January 5, 2026, with additional literature surveillance through June 29, 2026. Randomized trials comparing protocolized intraoperative arterial pressure-targeting strategies with usual care or lower-pressure approaches were included. The primary outcome was all-cause mortality; secondary outcomes were acute kidney injury (AKI) and myocardial injury after noncardiac surgery (MINS). Bayesian random-effects meta-analysis was prespecified as the primary analytical framework, with confirmatory frequentist analyses. Results: Fifteen randomized trials met the inclusion criteria. Mortality (13 trials) remained centered around an OR of 1.00 (frequentist OR 1.00, 95% CI 0.83–1.21; Bayesian median OR 1.00, 95% CrI 0.73–1.38), with wide Bayesian prediction intervals (OR 0.56–1.78). AKI (14 trials) showed the most favorable estimates (frequentist OR 0.87, 95% CI 0.73–1.03; Bayesian median OR 0.88, 95% CrI 0.70–1.05), but estimates remained compatible with no clinically important benefit, heterogeneity was moderate, and leave-one-out analyses, excluding each trial in turn, showed sensitivity to individual-trial exclusion. MINS (8 trials) likewise remained compatible with no treatment effect (frequentist OR 1.04, 95% CI 0.93–1.15; Bayesian median OR 1.05, 95% CrI 0.90–1.26). Exploratory analyses suggested that any potential renal benefit may depend on the broader hemodynamic context in which arterial pressure targets are implemented. Conclusions: Protocolized intraoperative arterial pressure-targeting strategies did not demonstrate a consistent incremental benefit over contemporary usual care in major noncardiac surgery. Mortality and MINS remained compatible with no treatment effect. Although AKI showed the most favorable estimates, the evidence remained uncertain, was sensitive to individual-trial exclusion, and should be interpreted cautiously.
- 28 September 2026
- Published by Wolters Kluwer Health in Anesthesiology
Intraoperative blood pressure targeting in noncardiac surgery: a Bayesian random-effects meta-analysis of randomized trials
Background: Whether protocolized intraoperative arterial pressure-targeting strategies provide incremental benefit beyond contemporary usual care remains uncertain. We performed a Bayesian meta-analysis of randomized trials in major noncardiac surgery. Methods: MEDLINE, Embase, and Cochrane CENTRAL were searched from inception to January 5, 2026, with additional literature surveillance through June 29, 2026. Randomized trials comparing protocolized intraoperative arterial pressure-targeting strategies with usual care or lower-pressure approaches were included. The primary outcome was all-cause mortality; secondary outcomes were acute kidney injury (AKI) and myocardial injury after noncardiac surgery (MINS). Bayesian random-effects meta-analysis was prespecified as the primary analytical framework, with confirmatory frequentist analyses. Results: Fifteen randomized trials met the inclusion criteria. Mortality (13 trials) remained centered around an OR of 1.00 (frequentist OR 1.00, 95% CI 0.83–1.21; Bayesian median OR 1.00, 95% CrI 0.73–1.38), with wide Bayesian prediction intervals (OR 0.56–1.78). AKI (14 trials) showed the most favorable estimates (frequentist OR 0.87, 95% CI 0.73–1.03; Bayesian median OR 0.88, 95% CrI 0.70–1.05), but estimates remained compatible with no clinically important benefit, heterogeneity was moderate, and leave-one-out analyses, excluding each trial in turn, showed sensitivity to individual-trial exclusion. MINS (8 trials) likewise remained compatible with no treatment effect (frequentist OR 1.04, 95% CI 0.93–1.15; Bayesian median OR 1.05, 95% CrI 0.90–1.26). Exploratory analyses suggested that any potential renal benefit may depend on the broader hemodynamic context in which arterial pressure targets are implemented. Conclusions: Protocolized intraoperative arterial pressure-targeting strategies did not demonstrate a consistent incremental benefit over contemporary usual care in major noncardiac surgery. Mortality and MINS remained compatible with no treatment effect. Although AKI showed the most favorable estimates, the evidence remained uncertain, was sensitive to individual-trial exclusion, and should be interpreted cautiously.
- 10 August 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 143 (4) , e54-e56
Provider-Level Distribution and Persistence of Lactated Ringer’s Solution and Normal Saline Use in US Medicaid, 2018–2024
Was not provided for this article.
- 10 August 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 143 (4) , e54-e56
Provider-Level Distribution and Persistence of Lactated Ringer’s Solution and Normal Saline Use in US Medicaid, 2018–2024
Was not provided for this article.
- 26 March 2025
- Published by Elsevier in Revista Española de Anestesiología y Reanimación (English Edition)
- Vol. 72 (8) , 501735
Anaesthesia evaluation and perioperative strategies in liver disease patients with cardiohepatic syndrome
- 26 March 2025
- Published by Elsevier in Revista Española de Anestesiología y Reanimación (English Edition)
- Vol. 72 (8) , 501735
Anaesthesia evaluation and perioperative strategies in liver disease patients with cardiohepatic syndrome